Siemens Healthineers has a released an informative eBook titled \u201cCoagulation abnormalities in COVID-19 patients \u2013 current testing and treatment protocols\u201d to provide quick access to coagulation testing and treatment recommendations.
\nThe eBook can be downloaded for free from their website: https:\/\/bit.ly\/2CcpB5I<\/link>\nBecause coagulation tests are important in the management of COVID-19 patients, the company has compiled an eBook for quick access to:<\/p>\n
The eBook provides an overview of COVID-19 and thrombosis; it looks at laboratory testing in the identification of coagulation abnormalities in COVID-19 patients; and provides information on the treatment of coagulation abnormalities in COVID-19 patients.
\nAuthors of the eBook write that while it\u2019s not unusual for infections to raise the risk of clotting, the COVID-19 virus is associated with an unprecedented range of clotting-related disorders in affected patients. \u201cFrom benign skin lesions on the feet to life-threatening thrombotic events, the COVID-19 virus has demonstrated a strikingly high prevalence of deadly blood clots. Studies show that about 25% and even up to 70% of critically ill patients have confirmed venous thromboembolism or pulmonary embolism. Another study found that approximately 70% of COVID-19 patients who died had disseminated intravascular coagulation.\u201d
\nThey add that Siemens Healthineers\u2019s coagulation tests play an important role in the diagnosis, treatment, and management of coagulation abnormalities in COVID-19 patients and point out that the company has changed their production model to produce these assays at a higher volume than ever before.
\n\u201cWe are proud to support you in the fight against COVID-19. Behind every healthcare professional there are 53,000 Healthineers,\u201d Siemens Healthineers says.
\n
\nSupplier:<\/strong> Siemens Healthineers
\nWebsite:<\/strong> <\/a><\/p>\n